Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

about

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

Item

http://www.wikidata.org/entity/Q52099813

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@en

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@nl

type

Item

label

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@en

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@nl

altLabel

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2

@en

prefLabel

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@en

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.

@nl

P1476

Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2

@en

P2093

Brian D Klein

http://www.w3.org/2001/XMLSchema#string

Daniel R McDougle

http://www.w3.org/2001/XMLSchema#string

Grzegorz Bulaj

http://www.w3.org/2001/XMLSchema#string

Liuyin Zhang

http://www.w3.org/2001/XMLSchema#string

Misty D Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Synthesis of galmic: a nonpeptide galanin receptor agonist

Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests

Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues

Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)

Developing novel antiepileptic drugs: characterization of NAX 5055, a systemically-active galanin analog, in epilepsy models

Galanin and galanin receptors in human cancers

Galanin and its receptors in neurological disorders

Galanin, galanin receptors and drug targets

P2888

s11064-017-2229-5

P304

1983-1994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11064-017-2229-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cameron S Metcalf

P577

2017-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28382595

http://www.w3.org/2001/XMLSchema#string

P921

P932

5505798

http://www.w3.org/2001/XMLSchema#string